PPI-2458

TERMINATED · PHASE1 · Non-Hodgkin's Lymphoma,, Solid Tumors

terminated due to corporate transaction.

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.